BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Seres, Vera Notch Weekend Wins in C.Diff, Lupus Trials

  Two experimental drugs from Seres Therapeutics and Vera Therapeutics celebrate clinical trial wins in hard-to-treat disease areas.

  May 23, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Alnylam Reports More Positive Data as Vutrisiran Awaits July FDA Date

  Alnylam Pharmaceuticals shared 18-month results from its phase III Helios-A clinical study demonstrating that vutrisiran improves clinical cardiac symptoms in patients with hATTR.

  May 23, 2022

   · 

  3 min read

   · 

  Jazmine Colatriano M.S.
• 

  Drug Development

  Elicio Touts “Huge Potential” for Cancer Vaccine Following Preclinical Data

  Elicio Therapeutics published data on the preprint server bioRxiv, describing preclinical research into its cancer vaccine that shows a lot of promise.

  May 23, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Potential Third US Case of Monkeypox Detected, but Officials Not Sounding Alarm

  Sunday night, U.S. health authorities announced that they may have found the third documented case of monkeypox in a patient in South Florida.

  May 23, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  Third Dose Appears to Be the Charm for Pfizer-BioNTech Vaccine in Young Kids

  Based on topline data, Pfizer stated that three doses of the COVID-19 vaccine met all immunobridging criteria required for EUA. The FDA’s advisory committee will meet June 15 to discuss the matter.

  May 23, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Business

  Vir Biotech, Wuxi Biologics End COVID-19 Antibody Collaboration

  Vir Biotechnology terminated a two-year-old COVID-19-related antibody collaboration with Wuxi Biologics that included sotrovimab, which lost EUA in the U.S. earlier this year.

  May 23, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Regeneron’s Evinacumab Fights Ultra-Rare Form of High Cholesterol in Kids

  Regeneron Pharmaceuticals shared positive results from its Phase III trial of an evinacumab for children with homozygous familial hypercholesterolemia.

  May 23, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Formula Shortage Highlights Supply Chain Concerns Facing Pharma Industry

  The crisis caused by the shutdown of one plant is a stark reminder of critical supply chain issues in other sectors, including the pharmaceutical industry.

  May 23, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Study: Lower Body Weight Related to Longer-Lasting COVID-19 Vaccine Immunity

  A small research study published in Jama shows people with a lower body mass index (BMI) tended to maintain immunity against COVID-19 longer.

  May 23, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  FDA Lifts Another Clinical Hold on Ocugen’s COVID-19 Vaccine Study

  Lifting the clinical hold will allow Ocugen to continue to assess the vaccine in its ongoing study and potentially support its efforts to achieve EUA or full approval.

  May 23, 2022

   · 

  2 min read

   · 

  Alex Keown